|
GAB2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62458935193399E-12 |
| Normal-vs-Stage2 |
7.5142000000028E-05 |
| Normal-vs-Stage3 |
5.06930053489896E-11 |
| Normal-vs-Stage4 |
2.53469999988987E-07 |
| Stage1-vs-Stage2 |
7.240800E-01 |
| Stage1-vs-Stage3 |
2.544200E-01 |
| Stage1-vs-Stage4 |
4.161600E-01 |
| Stage2-vs-Stage3 |
3.740000E-01 |
| Stage2-vs-Stage4 |
8.154000E-01 |
| Stage3-vs-Stage4 |
1.629830E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
8.006800E-04 |
| Normal-vs-Asian |
3.5094999994989E-07 |
| Caucasian-vs-AfricanAmerican |
3.124000E-01 |
| Caucasian-vs-Asian |
6.353600E-01 |
| AfricanAmerican-vs-Asian |
2.365600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.20090004607221E-09 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.147190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.66533453693773E-15 |
| Normal-vs-Age(41-60Yrs) |
7.99360577730113E-15 |
| Normal-vs-Age(61-80Yrs) |
1.43089999959933E-07 |
| Normal-vs-Age(81-100Yrs) |
4.620200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.477400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.127600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.864600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.759600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.463300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.965900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.362200E-01 |
| Classical-VS-Follicular |
8.464200E-03 |
| Classical-VS-Other |
8.260400E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
6.013600E-02 |
| Tall-VS-Other |
8.859800E-01 |
| Tall-VS-Normal |
1.09469999731715E-08 |
| Follicular-VS-Other |
5.995800E-01 |
| Follicular-VS-Normal |
2.374300E-04 |
| Other-VS-Normal |
2.098800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.95743421471661E-12 |
| Normal-vs-N1 |
1.85382999999817E-05 |
| N0-vs-N1 |
7.007400E-01 |
|
|
